(Q38131032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

8 March 2020

main subject

0 references

author

Lai-Shan Tam

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Shui-Lian Yu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Chun-Kwok Wong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

1 reference

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

739-749

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971752%20AND%20SRC:MED&resulttype=core&format=json

The role of innate immunity in the induction of autoimmunity

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Pathogen recognition by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Alarmins: chemotactic activators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

HMGB1 and RAGE in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Interleukin-33 - cytokine of dual function or novel alarmin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

HMGB1: a smoking gun in lupus nephritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

HMGB1: a signal of necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

RAGE signaling in inflammation and arterial aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Soluble forms of RAGE in human diseases: clinical and therapeutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

RAGE and the pathogenesis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The inflammatory response to ischemic acute kidney injury: a result of the 'right stuff' in the 'wrong place'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Soluble receptor for advanced glycation end products in patients with decreased renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Soluble forms of RAGE in internal medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Enhanced expression of receptor for advanced glycation end products in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Danger signals activating the immune response after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

21 January 2018

IL-33: a Janus cytokine

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Interleukin-33 biology with potential insights into human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Role of IL-33 in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33 and IL-33 receptors in host defense and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Fibrosis, chronic inflammation and new pathways for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Molecular pathways as novel therapeutic targets in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Effects of interleukin-33 on cardiac fibroblast gene expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Nuclear expression of interleukin-33 in pancreatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

IL-33 exacerbates acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Accuracy of the Flow Convergence Method for Quantification of Aortic Regurgitation in Patients With Central Versus Eccentric Jets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428

Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2013.814428